Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jan;67(1):152–155. doi: 10.1038/bjc.1993.26

Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.

Y Yang 1, G D Chisholm 1, F K Habib 1
PMCID: PMC1968204  PMID: 7678977

Abstract

We measured immunoreactive EGF and TGF alpha in prostate tissue extracts obtained from 19 patients with benign prostatic hyperplasia (BPH) and 19 with cancer of the prostate (CaP). Whilst both BPH and CaP expressed EGF (BPH = 195.61 +/- 19.94 ng g-1 protein; CaP = 235.60 +/- 24.45 ng g-1 protein) and TGF alpha (BPH = 92.57 +/- 7.60 ng g-1 protein; CaP = 100.73 +/- 15.47 ng g-1 protein) in equal concentrations, the levels of EGF in any tissue extract were on average twice those of TGF alpha. Furthermore analysis of the individual growth factor data revealed a direct correlation between EGF and TGF alpha in both BPH (r = 0.72, P < 0.001) and CaP (r = 0.69, P < 0.001). When the tumours were classified according to their Gleason score, a slight but significant increase in growth factor concentrations was noted as the tumour became less differentiated. We also measured the concentrations of testosterone and dihydrotestosterone (DHT) in prostate extracts with a view of elucidating the relationship between androgen and growth factors in this gland. There was a small positive correlation only between testosterone and EGF (r = 0.62, P < 0.05) and testosterone and TGF alpha (r = 0.61, P < 0.05) in CaP. The absence of any similar correlation in BPH where DHT becomes the predominant hormone may suggest an indirect role for testosterone in the regulation of growth factor production.

Full text

PDF
152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  2. Coffey R. J., Jr, Derynck R., Wilcox J. N., Bringman T. S., Goustin A. S., Moses H. L., Pittelkow M. R. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. 1987 Aug 27-Sep 2Nature. 328(6133):817–820. doi: 10.1038/328817a0. [DOI] [PubMed] [Google Scholar]
  3. Connolly J. M., Rose D. P. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate. 1989;15(2):177–186. doi: 10.1002/pros.2990150211. [DOI] [PubMed] [Google Scholar]
  4. Dickson R. B., Bates S. E., McManaway M. E., Lippman M. E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 1986 Apr;46(4 Pt 1):1707–1713. [PubMed] [Google Scholar]
  5. Fowler J. E., Jr, Lau J. L., Ghosh L., Mills S. E., Mounzer A. Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J Urol. 1988 Apr;139(4):857–861. doi: 10.1016/s0022-5347(17)42662-0. [DOI] [PubMed] [Google Scholar]
  6. Gomella L. G., Sargent E. R., Wade T. P., Anglard P., Linehan W. M., Kasid A. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res. 1989 Dec 15;49(24 Pt 1):6972–6975. [PubMed] [Google Scholar]
  7. Gregory H., Willshire I. R., Kavanagh J. P., Blacklock N. J., Chowdury S., Richards R. C. Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci (Lond) 1986 Apr;70(4):359–363. doi: 10.1042/cs0700359. [DOI] [PubMed] [Google Scholar]
  8. Habib F. K., Lee I. R., Stitch S. R., Smith P. H. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J Endocrinol. 1976 Oct;71(1):99–107. doi: 10.1677/joe.0.0710099. [DOI] [PubMed] [Google Scholar]
  9. Hofer D. R., Sherwood E. R., Bromberg W. D., Mendelsohn J., Lee C., Kozlowski J. M. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res. 1991 Jun 1;51(11):2780–2785. [PubMed] [Google Scholar]
  10. Houston B., Chisholm G. D., Habib F. K. Solubilization of human prostatic 5 alpha-reductase. J Steroid Biochem. 1985 Apr;22(4):461–467. doi: 10.1016/0022-4731(85)90163-3. [DOI] [PubMed] [Google Scholar]
  11. Jaspar J. M., Franchimont P. Radioimmunoassay of human epidermal growth factor in human breast cyst fluid. Eur J Cancer Clin Oncol. 1985 Nov;21(11):1343–1348. doi: 10.1016/0277-5379(85)90315-3. [DOI] [PubMed] [Google Scholar]
  12. Lai L. C., Ghilchik M. W., Shaikh N. A., Reed M. J., James V. H. Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. Br J Cancer. 1989 Sep;60(3):320–323. doi: 10.1038/bjc.1989.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lippman M. E., Dickson R. B., Kasid A., Gelmann E., Davidson N., McManaway M., Huff K., Bronzert D., Bates S., Swain S. Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem. 1986 Jan;24(1):147–154. doi: 10.1016/0022-4731(86)90044-0. [DOI] [PubMed] [Google Scholar]
  14. Liu C., Woo A., Tsao M. S. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer. 1990 Sep;62(3):425–429. doi: 10.1038/bjc.1990.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lloyd S. N., Brown I. L., Leake R. E. Transforming growth factor-alpha expression in benign and malignant human prostatic disease. Int J Biol Markers. 1992 Jan-Mar;7(1):27–34. [PubMed] [Google Scholar]
  16. MacDonald A., Chisholm G. D., Habib F. K. Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer. 1990 Oct;62(4):579–584. doi: 10.1038/bjc.1990.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MacDonald A., Habib F. K. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer. 1992 Feb;65(2):177–182. doi: 10.1038/bjc.1992.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maddy S. Q., Chisholm G. D., Busuttil A., Habib F. K. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. Br J Cancer. 1989 Jul;60(1):41–44. doi: 10.1038/bjc.1989.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marquardt H., Hunkapiller M. W., Hood L. E., Twardzik D. R., De Larco J. E., Stephenson J. R., Todaro G. J. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4684–4688. doi: 10.1073/pnas.80.15.4684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Perheentupa J., Lakshmanan J., Hoath S. B., Fisher D. A. Hormonal modulation of mouse plasma concentration of epidermal growth factor. Acta Endocrinol (Copenh) 1984 Dec;107(4):571–576. doi: 10.1530/acta.0.1070571. [DOI] [PubMed] [Google Scholar]
  21. Sporn M. B., Roberts A. B. Autocrine growth factors and cancer. 1985 Feb 28-Mar 6Nature. 313(6005):745–747. doi: 10.1038/313745a0. [DOI] [PubMed] [Google Scholar]
  22. St-Arnaud R., Poyet P., Walker P., Labrie F. Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol Cell Endocrinol. 1988 Mar;56(1-2):21–27. doi: 10.1016/0303-7207(88)90004-4. [DOI] [PubMed] [Google Scholar]
  23. Traish A. M., Wotiz H. H. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology. 1987 Oct;121(4):1461–1467. doi: 10.1210/endo-121-4-1461. [DOI] [PubMed] [Google Scholar]
  24. Winkler M. E., O'Connor L., Winget M., Fendly B. Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor. Biochemistry. 1989 Jul 25;28(15):6373–6378. doi: 10.1021/bi00441a033. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES